ArticleEuropean journal of clinical nutrition2026
Prevalence and impact of sarcopenic obesity at hospital admission according to ESPEN-EASO approach on functional status of older adults: results of a retrospective and prospective observational study.
Article in European journal of clinical nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesSarcopenic obesity (SO) is associated with adverse outcomes. This study aimed to assess the prevalence of SO diagnosed using the ESPEN-EASO approach and its correlations with functional impairment in an acute geriatric setting. SUBJECTS/
methodsObservational study including 453 older adults admitted to a Geriatric Unit. According to the ESPEN-EASO approach, patients were screened for obesity (BMI), assessed for handgrip strength (HGS, dynamometry), and body composition (bioimpedance analysis). SO was defined by low HGS, reduced relative to body weight skeletal muscle mass (SMM%), and increased relative fat mass (FM%). Screen-positive patients not meeting SO criteria were classified as obese (OB). Screen-negative patients with low SMM% and HGS were defined as sarcopenic (SARC); the remaining served as control (NS-NO). Functional status was investigated by IADL and by basal ADL collected at admission, during hospitalization, and at discharge and analyzed using trajectory modeling and univariate and multivariate adjusted models.
resultsAmong enrolled patients (mean age: 84.9 ± 7.0 y, F: 236, 52.1%), 36 (7.9%) had SO, 65 (14.3%) OB, 98 (21.0%) SARC, and 254 (56.7%) NS-NO. In multivariate analyses (NS-NO as reference) only SO demonstrated an increased risk of impaired ADL at discharge while OB and SARC did not. Trajectory modeling confirmed an SO-specific association with functional impairment followed by lower ADL recovery. Age, malnutrition, and cognitive impairment were independently associated with reduced ADL at admission and at discharge and with IADL.
conclusionsSarcopenic obesity is associated with a higher risk of poor ADL at discharge, emphasizing the importance of personalized obesity phenotyping in hospitalized older adults.
Identifiers
42859214What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.